255 related articles for article (PubMed ID: 28780736)
21. Vaccination in children with immune-mediated disorders.
Marinho AKBB
J Pediatr (Rio J); 2023; 99 Suppl 1(Suppl 1):S62-S69. PubMed ID: 36566017
[TBL] [Abstract][Full Text] [Related]
22. A Review of Vaccinations in Adult Patients with Secondary Immunodeficiency.
Righi E; Gallo T; Azzini AM; Mazzaferri F; Cordioli M; Merighi M; Tacconelli E
Infect Dis Ther; 2021 Jun; 10(2):637-661. PubMed ID: 33687662
[TBL] [Abstract][Full Text] [Related]
23. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep; 1994 Jan; 43(RR-1):1-38. PubMed ID: 8145710
[TBL] [Abstract][Full Text] [Related]
24. Immunization of HIV-infected adult patients - French recommendations.
Frésard A; Gagneux-Brunon A; Lucht F; Botelho-Nevers E; Launay O
Hum Vaccin Immunother; 2016 Nov; 12(11):2729-2741. PubMed ID: 27409293
[TBL] [Abstract][Full Text] [Related]
25. Insights on common vaccinations in HIV-infection: efficacy and safety.
Nicolini LA; Giacobbe DR; Di Biagio A; Viscoli C
J Prev Med Hyg; 2015 Jun; 56(1):E28-32. PubMed ID: 26789829
[TBL] [Abstract][Full Text] [Related]
26. Immune response to 2009 H1N1 vaccine in HIV-infected adults in Northern Thailand.
Chotirosniramit N; Sugandhavesa P; Aurpibul L; Thetket S; Kosashunhanan N; Supindham T; Wongkulab P; Kaewpoowat Q; Chaiklang K; Kaewthip O; Sroysuwan P; Wongthanee A; Lerdsamran H; Puthavathana P; Suparatpinyo K
Hum Vaccin Immunother; 2012 Dec; 8(12):1854-9. PubMed ID: 22906932
[TBL] [Abstract][Full Text] [Related]
27. Influenza and pneumococcal vaccination of HIV-infected patients: a policy analysis.
Rose DN; Schechter CB; Sacks HS
Am J Med; 1993 Feb; 94(2):160-8. PubMed ID: 8094271
[TBL] [Abstract][Full Text] [Related]
28. Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial.
Ndiaye BP; Thienemann F; Ota M; Landry BS; Camara M; Dièye S; Dieye TN; Esmail H; Goliath R; Huygen K; January V; Ndiaye I; Oni T; Raine M; Romano M; Satti I; Sutton S; Thiam A; Wilkinson KA; Mboup S; Wilkinson RJ; McShane H;
Lancet Respir Med; 2015 Mar; 3(3):190-200. PubMed ID: 25726088
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.
King JC; Treanor J; Fast PE; Wolff M; Yan L; Iacuzio D; Readmond B; O'Brien D; Mallon K; Highsmith WE; Lambert JS; Belshe RB
J Infect Dis; 2000 Feb; 181(2):725-8. PubMed ID: 10669363
[TBL] [Abstract][Full Text] [Related]
30. Immunological and Clinical Responses to Vaccinations among Adults Living with HIV.
Bieńkowski C; Żak Z; Fijołek F; Cholewik M; Stępień M; Skrzat-Klapaczyńska A; Kowalska JD
Life (Basel); 2024 Apr; 14(5):. PubMed ID: 38792562
[TBL] [Abstract][Full Text] [Related]
31. Immunogenicity and safety of pneumococcal conjugate polysaccharide and free polysaccharide vaccines alone or combined in HIV-infected adults in Brazil.
Ho YL; Brandão AP; de Cunto Brandileone MC; Lopes MH
Vaccine; 2013 Aug; 31(37):4047-53. PubMed ID: 23684823
[TBL] [Abstract][Full Text] [Related]
32. Efficacy, Immunogenicity and Safety of Vaccination in Pediatric Patients With Autoimmune Inflammatory Rheumatic Diseases (pedAIIRD): A Systematic Literature Review for the 2021 Update of the EULAR/PRES Recommendations.
Jansen MH; Rondaan C; Legger G; Minden K; Uziel Y; Toplak N; Maritsi D; van den Berg M; Berbers G; Bruijning P; Egert Y; Normand C; Bijl M; Foster H; Kone-Paut I; Wouters C; Ravelli A; Elkayam O; Wulffraat NM; Heijstek MW
Front Pediatr; 2022; 10():910026. PubMed ID: 35874582
[TBL] [Abstract][Full Text] [Related]
33. Surveillance of Vaccination Coverage among Adult Populations - United States, 2015.
Williams WW; Lu PJ; O'Halloran A; Kim DK; Grohskopf LA; Pilishvili T; Skoff TH; Nelson NP; Harpaz R; Markowitz LE; Rodriguez-Lainz A; Fiebelkorn AP
MMWR Surveill Summ; 2017 May; 66(11):1-28. PubMed ID: 28472027
[TBL] [Abstract][Full Text] [Related]
34. Travel vaccination recommendations and infection risk in HIV-positive travellers.
Chang L; Lim BCW; Flaherty GT; Torresi J
J Travel Med; 2019 Sep; 26(6):. PubMed ID: 31066446
[TBL] [Abstract][Full Text] [Related]
35. Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group.
Graham BS; Keefer MC; McElrath MJ; Gorse GJ; Schwartz DH; Weinhold K; Matthews TJ; Esterlitz JR; Sinangil F; Fast PE
Ann Intern Med; 1996 Aug; 125(4):270-9. PubMed ID: 8678389
[TBL] [Abstract][Full Text] [Related]
36. Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1.
Mothe B; Climent N; Plana M; Rosàs M; Jiménez JL; Muñoz-Fernández MÁ; Puertas MC; Carrillo J; Gonzalez N; León A; Pich J; Arnaiz JA; Gatell JM; Clotet B; Blanco J; Alcamí J; Martinez-Picado J; Alvarez-Fernández C; Sánchez-Palomino S; Guardo AC; Peña J; Benito JM; Rallón N; Gómez CE; Perdiguero B; García-Arriaza J; Esteban M; López Bernaldo de Quirós JC; Brander C; García F;
J Antimicrob Chemother; 2015; 70(6):1833-42. PubMed ID: 25724985
[TBL] [Abstract][Full Text] [Related]
37. A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial.
Lévy Y; Lacabaratz C; Lhomme E; Wiedemann A; Bauduin C; Fenwick C; Foucat E; Surenaud M; Guillaumat L; Boilet V; Rieux V; Bouchaud O; Girard PM; Molina JM; Morlat P; Hocqueloux L; Richert L; Pantaleo G; Lelièvre JD; Thiébaut R
J Virol; 2021 Apr; 95(9):. PubMed ID: 33568510
[TBL] [Abstract][Full Text] [Related]
38. Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge.
Styles TM; Gangadhara S; Reddy PBJ; Hicks S; LaBranche CC; Montefiori DC; Derdeyn CA; Kozlowski PA; Velu V; Amara RR
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341049
[TBL] [Abstract][Full Text] [Related]
39. Safety of licensed vaccines in HIV-infected persons: a systematic review protocol.
Kagina BM; Wiysonge CS; Lesosky M; Madhi SA; Hussey GD
Syst Rev; 2014 Sep; 3():101. PubMed ID: 25212760
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B and A vaccination in HIV-infected adults: A review.
Mena G; García-Basteiro AL; Bayas JM
Hum Vaccin Immunother; 2015; 11(11):2582-98. PubMed ID: 26208678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
